Infertility has emerged as a significant public health concern, with assisted reproductive technology (ART) is a last-resort treatment option. However, ART's efficacy is limited by significant financial cost and physical discomfort. The aim of this study is to build Machine learning (ML) decision-support models to predict the optimal range of embryo numbers to transfer, using data from infertile couples identified through literature reviews. Binary classification models were developed to classify cases into two groups: those transferring two or fewer embryos and those transferring three or four. Four popular ML algorithms were used, including random forest (RF), logistic regression (LR), support vector machine (SVM), and artificial neural network (ANN), considering seven criteria: the woman's age, sperm origin, the developmental qualities of four potential embryos, infertility duration, assessment of the woman, morphological qualities of the four best embryos on the day of transfer, and number of oocytes extracted. The stratified 3-fold cross-validation results show that the SVM model obtained the highest average accuracy (95.83%) and demonstrated the best overall performance, closely followed by the ANN and LR models with an average accuracy equal to 91.67%. The RF model achieved a slightly lower average accuracy (88.89%), which demonstrated the lowest variability. Testing on a new dataset revealed all models performed well, with ANN and SVM models classified all test set instances correctly, while the RF and LR models achieved 91.68% accuracy. These results highlight the superior generalization and effectiveness of the ANN and SVM models in guiding ART decisions.

BackgroundResearch on degenerative abdominal aortic aneurysms (AAA) is hampered by complex pathophysiology, sub-optimal pre-clinical models, and lack of effective medical therapies. In addition, trustworthiness of existing epidemiological data is impaired by elements of ambiguity, inaccuracy, and inconsistency. Our aim is to foster debate concerning the trustworthiness of AAA epidemiological data and to discuss potential solutions.MethodsWe searched the literature from the last five decades for relevant epidemiological data concerning AAA development, rupture, and repair. We then discussed the main issues burdening existing AAA epidemiological figures and proposed suggestions potentially beneficial to AAA diagnosis, prognostication, and management.ResultsRecent data suggest a heterogeneous scenario concerning AAA epidemiology with rates markedly varying by country and study cohorts. Overall, AAA prevalence seems to be decreasing worldwide while mortality is apparently increasing regardless of recent improvements in aortic-repair techniques. Prevalence and mortality are decreasing in high-income countries, whereas low-income countries show an increase in both. However, several pieces of information are missing or outdated, thus systematic renewal is necessary. Current AAA definition and surgical criteria do not consider inter-individual variability of baseline aortic size, further decreasing their reliability.ConclusionsSwitching from flat aortic-size thresholds to relative aortic indices would improve epidemiological trustworthiness regarding AAAs. Aortometry standardization focusing on simplicity, univocity, and accuracy is crucial. A patient-tailored approach integrating clinical data, multi-adjusted indices, and imaging parameters is desirable. Several novel imaging modalities boast promising profiles for investigating the aortic wall. New contrast agents, computational analyses, and artificial intelligence-powered software could provide further improvements.

Current care in multiple sclerosis (MS) primarily relies on infrequently obtained data such as magnetic resonance imaging, clinical laboratory tests or clinical history, resulting in subtle changes that may occur between visits being missed. Mobile technology enables continual collection of data and can pave the path for predicting complex aspects of MS such as symptoms and disease courses. To this end, we conducted a first-of-its-kind observational study called MS Mosaic. First, we developed and publicly launched a mobile app for collecting longitudinal data from MS subjects in the United States. Second, we ran the study across 3 years in order to capture complex patterns for this slow progressing disease. Finally, we retrospectively developed three classical ML methods and two deep learning models to accurately and continually predict the incidence of five high-severity symptoms (fatigue, sensory disturbance, walking instability, depression or anxiety and cramps/spasms) three months in advance.

This retrospective study evaluates the diagnostic performance of an optimized comprehensive multi-stage framework based on the Segment Anything Model (SAM), which we named Dr-SAM, for detecting and grading vascular stenosis in the abdominal aorta and iliac arteries using digital subtraction angiography (DSA).

A total of 100 DSA examinations were conducted on 100 patients. The infrarenal abdominal aorta (AAI), common iliac arteries (CIA), and external iliac arteries (EIA) were independently evaluated by two experienced radiologists using a standardized 5-point grading scale. Dr-SAM analyzed the same DSA images, and its assessments were compared with the average stenosis grading provided by the radiologists. Diagnostic accuracy was evaluated using Cohen's kappa, specificity, sensitivity, and Wilcoxon signed-rank tests.

Interobserver agreement between radiologists, which established the reference standard, was strong (Cohen's kappa: CIA right = 0.95, CIA left = 0.94, EIA right = 0.98, EIA left = 0.98, AAI = 0.79). Dr-SAM showed high agreement with radiologist consensus for CIA (κ = 0.93 right, 0.91 left), moderate agreement for EIA (κ = 0.79 right, 0.76 left), and fair agreement for AAI (κ = 0.70). Dr-SAM demonstrated excellent specificity (up to 1.0) and robust sensitivity (0.67-0.83). Wilcoxon tests revealed no significant differences between Dr-SAM and radiologist grading (p > 0.05).

Dr-SAM proved to be an accurate and efficient tool for vascular assessment, with the potential to streamline diagnostic workflows and reduce variability in stenosis grading. Its ability to deliver rapid and consistent evaluations may contribute to earlier detection of disease and the optimization of treatment strategies. Further studies are needed to confirm these findings in prospective settings and to enhance its capabilities, particularly in the detection of occlusions.

This study aims to establish a large degenerative cervical myelopathy cohort and develop deep learning models for predicting cervical canal stenosis from sagittal T2-weighted MRI.

Data was collected retrospectively from patients who underwent a cervical spine MRI from January 2007 to December 2022 at a single institution. Ground truth labels for cervical canal stenosis were obtained from sagittal T2-weighted MRI using Kang's grade, a four-level scoring system that classifies stenosis with the degree of subarachnoid space obliteration and cord indentation. ResNet50, VGG16, MobileNetV3, and EfficientNetV2 were trained using threefold cross-validation, and the models exhibiting the largest area under the receiver operating characteristic curve (AUC) were selected to produce the ensemble model. Gradient-weighted class activation mapping was adopted for qualitative assessment. Models that incorporate demographic features were trained, and their corresponding AUCs on the test set were evaluated.

Of 8676 patients, 7645 were eligible for developing deep learning models, where 6880 (mean age, 56.0 ± 14.3 years, 3480 men) were used for training while 765 (mean age, 56.5 ± 14.4 years, 386 men) were set aside for testing. The ensemble model exhibited the largest AUC of 0.95 (0.94-0.97). Accuracy was 0.875 (0.851-0.898), sensitivity was 0.885 (0.855-0.915), and specificity was 0.861 (0.824-0.898). Qualitative analyses demonstrated that the models accurately pinpoint radiologic findings suggestive of cervical canal stenosis and myelopathy. Incorporation of demographic features did not result in a gain of AUC.

We have developed deep learning models from a large degenerative cervical myelopathy cohort and thoroughly explored their robustness and explainability.

Background: The leading global cause of death is coronary artery disease (CAD), necessitating early and precise diagnosis. Intravascular ultrasound (IVUS) is a sophisticated imaging technique that provides detailed visualization of coronary arteries. However, the methods for segmenting walls in the IVUS scan into internal wall structures and quantifying plaque are still evolving. This study explores the use of transformers and attention-based models to improve diagnostic accuracy for wall segmentation in IVUS scans. Thus, the objective is to explore the application of transformer models for wall segmentation in IVUS scans to assess their inherent biases in artificial intelligence systems for improving diagnostic accuracy. Methods: By employing the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) framework, we pinpointed and examined the top strategies for coronary wall segmentation using transformer-based techniques, assessing their traits, scientific soundness, and clinical relevancy. Coronary artery wall thickness is determined by using the boundaries (inner: lumen-intima and outer: media-adventitia) through cross-sectional IVUS scans. Additionally, it is the first to investigate biases in deep learning (DL) systems that are associated with IVUS scan wall segmentation. Finally, the study incorporates explainable AI (XAI) concepts into the DL structure for IVUS scan wall segmentation. Findings: Because of its capacity to automatically extract features at numerous scales in encoders, rebuild segmented pictures via decoders, and fuse variations through skip connections, the UNet and transformer-based model stands out as an efficient technique for segmenting coronary walls in IVUS scans. Conclusions: The investigation underscores a deficiency in incentives for embracing XAI and pruned AI (PAI) models, with no UNet systems attaining a bias-free configuration. Shifting from theoretical study to practical usage is crucial to bolstering clinical evaluation and deployment.

Accurate and precise identification of cholelithiasis is essential for saving the lives of millions of people worldwide. Although several computer-aided cholelithiasis diagnosis approaches have been introduced in the literature, their use is limited because Convolutional Neural Network (CNN) models are black box in nature. Therefore, a novel approach for cholelithiasis classification using custom CNN with post-hoc model explanation is proposed. This paper presents multiple contributions. First, a custom CNN architecture is proposed to classify and predict cholelithiasis from ultrasound image. Second, a modified deep convolutional generative adversarial network is proposed to produce synthetic ultrasound images for better model generalization. Third, a hybrid visual explanation method is proposed by combining gradient-weighted class activation with local interpretable model agnostic explanation to generate a visual explanation using a heatmap. Fourth, an exhaustive performance analysis of the proposed approach on ultrasound images collected from three different Indian hospitals is presented to showcase its efficacy for computer-aided cholelithiasis diagnosis. Fifth, a team of radiologists evaluates and validates the prediction and respective visual explanations made using the proposed approach. The results reveal that the proposed cholelithiasis classification approach beats the performance of state-of-the-art pre-trained CNN and Vision Transformer models. The heatmap generated through the proposed hybrid explanation method offers detailed visual explanations to enhance transparency and trustworthiness in the medical domain.

The aim of this study was to explore the potential of weak supervision in a deep learning-based label prediction model. The goal was to use this model to extract labels from German free-text thoracic radiology reports on chest X-ray images and for training chest X-ray classification models.The proposed label extraction model for German thoracic radiology reports uses a German BERT encoder as a backbone and classifies a report based on the CheXpert labels. For investigating the efficient use of manually annotated data, the model was trained using manual annotations, weak rule-based labels, and both. Rule-based labels were extracted from 66071 retrospectively collected radiology reports from 2017-2021 (DS 0), and 1091 reports from 2020-2021 (DS 1) were manually labeled according to the CheXpert classes. Label extraction performance was evaluated with respect to mention extraction, negation detection, and uncertainty detection by measuring F1 scores. The influence of the label extraction method on chest X-ray classification was evaluated on a pneumothorax data set (DS 2) containing 6434 chest radiographs with associated reports and expert diagnoses of pneumothorax. For this, DenseNet-121 models trained on manual annotations, rule-based and deep learning-based label predictions, and publicly available data were compared.The proposed deep learning-based labeler (DL) performed on average considerably stronger than the rule-based labeler (RB) for all three tasks on DS 1 with F1 scores of 0.938 vs. 0.844 for mention extraction, 0.891 vs. 0.821 for negation detection, and 0.624 vs. 0.518 for uncertainty detection. Pre-training on DS 0 and fine-tuning on DS 1 performed better than only training on either DS 0 or DS 1. Chest X-ray pneumothorax classification results (DS 2) were highest when trained with DL labels with an area under the receiver operating curve (AUC) of 0.939 compared to RB labels with an AUC of 0.858. Training with manual labels performed slightly worse than training with DL labels with an AUC of 0.934. In contrast, training with a public data set resulted in an AUC of 0.720.Our results show that leveraging a rule-based report labeler for weak supervision leads to improved labeling performance. The pneumothorax classification results demonstrate that our proposed deep learning-based labeler can serve as a substitute for manual labeling requiring only 1000 manually annotated reports for training. · The proposed deep learning-based label extraction model for German thoracic radiology reports performs better than the rule-based model.. · Training with limited supervision outperformed training with a small manually labeled data set.. · Using predicted labels for pneumothorax classification from chest radiographs performed equally to using manual annotations.. Wollek A, Haitzer P, Sedlmeyr T et al. Language modelbased labeling of German thoracic radiology reports. Fortschr Röntgenstr 2024; DOI 10.1055/a-2287-5054.

Ultrasound (US) imaging is an essential diagnostic technique in prenatal care, enabling enhanced surveillance of fetal growth and development. Fetal ultrasonography standard planes are crucial for evaluating fetal development parameters and detecting abnormalities. Real-time imaging, low cost, non-invasiveness, and accessibility make US imaging indispensable in clinical practice. However, acquiring fetal US planes with correct fetal anatomical features is a difficult and time-consuming task, even for experienced sonographers. Medical imaging using AI shows promise for addressing current challenges. In response to this challenge, a Deep Learning (DL)-based automated categorization method for maternal fetal US planes are introduced to enhance detection efficiency and diagnosis accuracy. This paper presents a hybrid optimization technique for feature selection and introduces a novel Radial Basis Function Neural Network (RBFNN) for reliable maternal fetal US plane classification. A large dataset of maternal-fetal screening US images was collected from publicly available sources and categorized into six groups: the four fetal anatomical planes, the mother's cervix, and an additional category. Feature extraction is performed using Gray-Level Co-occurrence Matrix (GLCM), and optimization methods such as Particle Swarm Optimization (PSO), Grey Wolf Optimization (GWO), and a hybrid Particle Swarm Optimization and Grey Wolf Optimization (PSOGWO) approach are utilized to select the most relevant features. The optimized features from each algorithm are then input into both conventional and proposed DL models. Experimental results indicate that the proposed approach surpasses conventional DL models in performance. Furthermore, the proposed model is evaluated against previously published models, showcasing its superior classification accuracy. In conclusion, our proposed approach provides a solid foundation for automating the classification of fetal US planes, leveraging optimization and DL techniques to enhance prenatal diagnosis and care.

During preclinical training, dental students take radiographs of acrylic (plastic) blocks containing extracted patient teeth. With the digitisation of medical records, a central archiving system was created to store and retrieve all x-ray images, regardless of whether they were images of teeth on acrylic blocks, or those from patients. In the early stage of the digitisation process, and due to the immaturity of the data management system, numerous images were mixed up and stored in random locations within a unified archiving system, including patient record files. Filtering out and expunging the undesired training images is imperative as manual searching for such images is problematic. Hence the aim of this stidy was to differentiate intraoral images from artificial images on acrylic blocks.

An artificial intelligence (AI) solution to automatically differentiate between intraoral radiographs taken of patients and those taken of acrylic blocks was utilised in this study. The concept of transfer learning was applied to a dataset provided by a Dental Hospital.

An accuracy score, F1 score, and a recall score of 98.8%, 99.2%, and 100%, respectively, were achieved using a VGG16 pre-trained model. These results were more sensitive compared to those obtained initally using a baseline model with 96.5%, 97.5%, and 98.9% accuracy score, F1 score, and a recall score respectively.

The proposed system using transfer learning was able to accurately identify "fake" radiographs images and distinguish them from the real intraoral images.

To present a systematic review of the state of the art regarding clinical applications, main features, and outcomes of artificial intelligence (AI) in orthognathic surgery.

The PICOS strategy was performed on a systematic review (SR) to answer the following question: "What are the state of the art, characteristics and outcomes of applications with artificial intelligence for orthognathic surgery?" After registering in PROSPERO (CRD42021270789) a systematic search was performed in the databases: PubMed (including MedLine), Scopus, Embase, LILACS, MEDLINE EBSCOHOST and Cochrane Library. 195 studies were selected, after screening titles and abstracts, of which thirteen manuscripts were included in the qualitative analysis and six in the quantitative analysis. The treatment effects were plotted in a Forest-plot. JBI questionnaire for observational studies was used to asses the risk of bias. The quality of the SR evidence was assessed using the GRADE tool.

AI studies on 2D cephalometry for orthognathic surgery, the Tau2 = 0.00, Chi2 = 3.78, p = 1.00 and I² of 0 %, indicating low heterogeneity, AI did not differ statistically from control (p = 0.79). AI studies in the diagnosis of the decision of whether or not to perform orthognathic surgery showed heterogeneity, and therefore meta-analysis was not peformed.

The outcome of AI is similar to the control group, with a low degree of bias, highlighting its potential for use in various applications.

To investigate the clinical feasibility and image quality of accelerated brain diffusion-weighted imaging (DWI) with deep learning image reconstruction and super resolution.

85 consecutive patients with clinically indicated MRI at a 3 T scanner were prospectively included. Conventional diffusion-weighted data (c-DWI) with four averages were obtained. Reconstructions of one and two averages, as well as deep learning diffusion-weighted imaging (DL-DWI), were accomplished. Three experienced readers evaluated the acquired data using a 5-point Likert scale regarding overall image quality, overall contrast, diagnostic confidence, occurrence of artefacts and evaluation of the central region, basal ganglia, brainstem, and cerebellum. To assess interrater agreement, Fleiss' kappa (ϰ) was determined. Signal intensity (SI) levels for basal ganglia and the central region were estimated via automated segmentation, and SI values of detected pathologies were measured.

Intracranial pathologies were identified in 35 patients. DL-DWI was significantly superior for all defined parameters, independently from applied averages (p-value <0.001). Optimum image quality was achieved with DL-DWI by utilizing a single average (p-value <0.001), demonstrating very good (80.9%) to excellent image quality (14.5%) in nearly all cases, compared to 12.5% with very good and 0% with excellent image quality for c-MRI (p-value <0.001). Comparable results could be shown for diagnostic confidence. Inter-rater Fleiss' Kappa demonstrated moderate to substantial agreement for virtually all defined parameters, with good accordance, particularly for the assessment of pathologies (p = 0.74). Regarding SI values, no significant difference was found.

Ultra-fast diffusion-weighted imaging with super resolution is feasible, resulting in highly accelerated brain imaging while increasing diagnostic image quality.

Cardiovascular diseases (CVD) cause 19 million fatalities each year and cost nations billions of dollars. Surrogate biomarkers are established methods for CVD risk stratification; however, manual inspection is costly, cumbersome, and error-prone. The contemporary artificial intelligence (AI) tools for segmentation and risk prediction, including older deep learning (DL) networks employ simple merge connections which may result in semantic loss of information and hence low in accuracy.

We hypothesize that DL networks enhanced with attention mechanisms can do better segmentation than older DL models. The attention mechanism can concentrate on relevant features aiding the model in better understanding and interpreting images. This study proposes MultiNet 2.0 (AtheroPoint, Roseville, CA, USA), two attention networks have been used to segment the lumen from common carotid artery (CCA) ultrasound images and predict CVD risks.

The database consisted of 407 ultrasound CCA images of both the left and right sides taken from 204 patients. Two experts were hired to delineate borders on the 407 images, generating two ground truths (GT1 and GT2). The results were far better than contemporary models. The lumen dimension (LD) error for GT1 and GT2 were 0.13±0.08 and 0.16±0.07 mm, respectively, the best in market. The AUC for low, moderate and high-risk patients' detection from stenosis data for GT1 were 0.88, 0.98, and 1.00 respectively. Similarly, for GT2, the AUC values for low, moderate, and high-risk patient detection were 0.93, 0.97, and 1.00, respectively. The system can be fully adopted for clinical practice in AtheroEdge™ model by AtheroPoint, Roseville, CA, USA.

The risk of cardiovascular disease (CVD) has traditionally been predicted via the assessment of carotid plaques. In the proposed study, AtheroEdge™ 3.0HDL (AtheroPoint™, Roseville, CA, USA) was designed to demonstrate how well the features obtained from carotid plaques determine the risk of CVD. We hypothesize that hybrid deep learning (HDL) will outperform unidirectional deep learning, bidirectional deep learning, and machine learning (ML) paradigms.

500 people who had undergone targeted carotid B-mode ultrasonography and coronary angiography were included in the proposed study. ML feature selection was carried out using three different methods, namely principal component analysis (PCA) pooling, the chi-square test (CST), and the random forest regression (RFR) test. The unidirectional and bidirectional deep learning models were trained, and then six types of novel HDL-based models were designed for CVD risk stratification. The AtheroEdge™ 3.0HDL was scientifically validated using seen and unseen datasets while the reliability and statistical tests were conducted using CST along with p-value significance. The performance of AtheroEdge™ 3.0HDL was evaluated by measuring the p-value and area-under-the-curve for both seen and unseen data.

The HDL system showed an improvement of 30.20% (0.954 vs. 0.702) over the ML system using the seen datasets. The ML feature extraction analysis showed 70% of common features among all three methods. The generalization of AtheroEdge™ 3.0HDL showed less than 1% (p-value < 0.001) difference between seen and unseen data, complying with regulatory standards.

The hypothesis for AtheroEdge™ 3.0HDL was scientifically validated, and the model was tested for reliability and stability and is further adaptable clinically.

Hepatocellular carcinoma (HCC) is a common primary liver cancer that requires early diagnosis due to its poor prognosis. Recent advances in artificial intelligence (AI) have facilitated hepatocellular carcinoma detection using multiple AI models; however, their performance is still uncertain.

This meta-analysis aimed to compare the diagnostic performance of different AI models with that of clinicians in the detection of hepatocellular carcinoma.

We searched the PubMed, Scopus, Cochrane Library, and Web of Science databases for eligible studies. The R package was used to synthesize the results. The outcomes of various studies were aggregated using fixed-effect and random-effects models. Statistical heterogeneity was evaluated using I-squared (I2) and chi-square statistics.

We included seven studies in our meta-analysis;. Both physicians and AI-based models scored an average sensitivity of 93%. Great variation in sensitivity, accuracy, and specificity was observed depending on the model and diagnostic technique used. The region-based convolutional neural network (RCNN) model showed high sensitivity (96%). Physicians had the highest specificity in diagnosing hepatocellular carcinoma(100%); furthermore, models-based convolutional neural networks achieved high sensitivity. Models based on AI-assisted Contrast-enhanced ultrasound (CEUS) showed poor accuracy (69.9%) compared to physicians and other models. The leave-one-out sensitivity revealed high heterogeneity among studies, which represented true differences among the studies.

Models based on Faster R-CNN excel in image classification and data extraction, while both CNN-based models and models combining contrast-enhanced ultrasound (CEUS) with artificial intelligence (AI) had good sensitivity. Although AI models outperform physicians in diagnosing HCC, they should be utilized as supportive tools to help make more accurate and timely decisions.

The field of precision medicine endeavors to transform the healthcare industry by advancing individualised strategies for diagnosis, treatment modalities, and predictive assessments. This is achieved by utilizing extensive multidimensional biological datasets encompassing diverse components, such as an individual's genetic makeup, functional attributes, and environmental influences. Artificial intelligence (AI) systems, namely machine learning (ML) and deep learning (DL), have exhibited remarkable efficacy in predicting the potential occurrence of specific cancers and cardiovascular diseases (CVD).

We conducted a comprehensive scoping review guided by the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) framework. Our search strategy involved combining key terms related to CVD and AI using the Boolean operator AND. In August 2023, we conducted an extensive search across reputable scholarly databases including Google Scholar, PubMed, IEEE Xplore, ScienceDirect, Web of Science, and arXiv to gather relevant academic literature on personalised medicine for CVD. Subsequently, in January 2024, we extended our search to include internet search engines such as Google and various CVD websites. These searches were further updated in March 2024. Additionally, we reviewed the reference lists of the final selected research articles to identify any additional relevant literature.

A total of 2307 records were identified during the process of conducting the study, consisting of 564 entries from external sites like arXiv and 1743 records found through database searching. After 430 duplicate articles were eliminated, 1877 items that remained were screened for relevancy. In this stage, 1241 articles remained for additional review after 158 irrelevant articles and 478 articles with insufficient data were removed. 355 articles were eliminated for being inaccessible, 726 for being written in a language other than English, and 281 for not having undergone peer review. Consequently, 121 studies were deemed suitable for inclusion in the qualitative synthesis. At the intersection of CVD, AI, and precision medicine, we found important scientific findings in our scoping review. Intricate pattern extraction from large, complicated genetic datasets is a skill that AI algorithms excel at, allowing for accurate disease diagnosis and CVD risk prediction. Furthermore, these investigations have uncovered unique genetic biomarkers linked to CVD, providing insight into the workings of the disease and possible treatment avenues. The construction of more precise predictive models and personalised treatment plans based on the genetic profiles of individual patients has been made possible by the revolutionary advancement of CVD risk assessment through the integration of AI and genomics.

The systematic methodology employed ensured the thorough examination of available literature and the inclusion of relevant studies, contributing to the robustness and reliability of the study's findings. Our analysis stresses a crucial point in terms of the adaptability and versatility of AI solutions. AI algorithms designed in non-CVD domains such as in oncology, often include ideas and tactics that might be modified to address cardiovascular problems.

No funding received.

Artificial intelligence (AI) models trained on multi-centric and multi-device studies can provide more robust insights and research findings compared to single-center studies. However, variability in acquisition protocols and equipment can introduce inconsistencies that hamper the effective pooling of multi-source datasets. This systematic review evaluates strategies for image harmonization, which standardizes appearances to enable reliable AI analysis of multi-source medical imaging.

A literature search using PRISMA guidelines was conducted to identify relevant papers published between 2013 and 2023 analyzing multi-centric and multi-device medical imaging studies that utilized image harmonization approaches.

Common image harmonization techniques included grayscale normalization (improving classification accuracy by up to 24.42 %), resampling (increasing the percentage of robust radiomics features from 59.5 % to 89.25 %), and color normalization (enhancing AUC by up to 0.25 in external test sets). Initially, mathematical and statistical methods dominated, but machine and deep learning adoption has risen recently. Color imaging modalities like digital pathology and dermatology have remained prominent application areas, though harmonization efforts have expanded to diverse fields including radiology, nuclear medicine, and ultrasound imaging. In all the modalities covered by this review, image harmonization improved AI performance, with increasing of up to 24.42 % in classification accuracy and 47 % in segmentation Dice scores.

Continued progress in image harmonization represents a promising strategy for advancing healthcare by enabling large-scale, reliable analysis of integrated multi-source datasets using AI. Standardizing imaging data across clinical settings can help realize personalized, evidence-based care supported by data-driven technologies while mitigating biases associated with specific populations or acquisition protocols.

The quantification of carotid plaque has been routinely used to predict cardiovascular risk in cardiovascular disease (CVD) and coronary artery disease (CAD). To determine how well carotid plaque features predict the likelihood of CAD and cardiovascular (CV) events using deep learning (DL) and compare against the machine learning (ML) paradigm. The participants in this study consisted of 459 individuals who had undergone coronary angiography, contrast-enhanced ultrasonography, and focused carotid B-mode ultrasound. Each patient was tracked for thirty days. The measurements on these patients consisted of maximum plaque height (MPH), total plaque area (TPA), carotid intima-media thickness (cIMT), and intraplaque neovascularization (IPN). CAD risk and CV event stratification were performed by applying eight types of DL-based models. Univariate and multivariate analysis was also conducted to predict the most significant risk predictors. The DL's model effectiveness was evaluated by the area-under-the-curve measurement while the CV event prediction was evaluated using the Cox proportional hazard model (CPHM) and compared against the DL-based concordance index (c-index). IPN showed a substantial ability to predict CV events (p < 0.0001). The best DL system improved by 21% (0.929 vs. 0.762) over the best ML system. DL-based CV event prediction showed a ~ 17% increase in DL-based c-index compared to the CPHM (0.86 vs. 0.73). CAD and CV incidents were linked to IPN and carotid imaging characteristics. For survival analysis and CAD prediction, the DL-based system performs superior to ML-based models.

This study delves into the cutting-edge field of deep learning techniques, particularly deep convolutional neural networks (DCNNs), which have demonstrated unprecedented potential in assisting radiologists and orthopedic surgeons in precisely identifying meniscal tears. This research aims to evaluate the effectiveness of deep learning models in recognizing, localizing, describing, and categorizing meniscal tears in magnetic resonance images (MRIs).

This systematic review was rigorously conducted, strictly following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Extensive searches were conducted on MEDLINE (PubMed), Web of Science, Cochrane Library, and Google Scholar. All identified articles underwent a comprehensive risk of bias analysis. Predictive performance values were either extracted or calculated for quantitative analysis, including sensitivity and specificity. The meta-analysis was performed for all prediction models that identified the presence and location of meniscus tears.

This study's findings underscore that a range of deep learning models exhibit robust performance in detecting and classifying meniscal tears, in one case surpassing the expertise of musculoskeletal radiologists. Most studies in this review concentrated on identifying tears in the medial or lateral meniscus and even precisely locating tears-whether in the anterior or posterior horn-with exceptional accuracy, as demonstrated by AUC values ranging from 0.83 to 0.94.

Based on these findings, deep learning models have showcased significant potential in analyzing knee MR images by learning intricate details within images. They offer precise outcomes across diverse tasks, including segmenting specific anatomical structures and identifying pathological regions. Contributions: This study focused exclusively on DL models for identifying and localizing meniscus tears. It presents a meta-analysis that includes eight studies for detecting the presence of a torn meniscus and a meta-analysis of three studies with low heterogeneity that localize and classify the menisci. Another novelty is the analysis of arthroscopic surgery as ground truth. The quality of the studies was assessed against the CLAIM checklist, and the risk of bias was determined using the QUADAS-2 tool.

Colorectal cancer (CRC) is a leading tumor worldwide. In CRC, the angiogenic pathway plays a crucial role in cancer development and the process of metastasis. Thus, anti-angiogenic drugs represent a milestone for metastatic CRC (mCRC) treatment and lead to significant improvement of clinical outcomes. Nevertheless, not all patients respond to treatment and some develop resistance. Therefore, the identification of predictive factors able to predict response to angiogenesis pathway blockade is required in order to identify the best candidates to receive these agents. Unfortunately, no predictive biomarkers have been prospectively validated to date. Over the years, research has focused on biologic factors such as genetic polymorphisms, circulating biomarkers, circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and microRNA. Moreover, research efforts have evaluated the potential correlation of molecular biomarkers with imaging techniques used for tumor assessment as well as the application of imaging tools in clinical practice. In addition to functional imaging, radiomics, a relatively newer technique, shows real promise in the setting of correlating molecular medicine to radiological phenotypes.

A significant issue in computer-aided diagnosis (CAD) for medical applications is brain tumor classification. Radiologists could reliably detect tumors using machine learning algorithms without extensive surgery. However, a few important challenges arise, such as (i) the selection of the most important deep learning architecture for classification (ii) an expert in the field who can assess the output of deep learning models. These difficulties motivate us to propose an efficient and accurate system based on deep learning and evolutionary optimization for the classification of four types of brain modalities (t1 tumor, t1ce tumor, t2 tumor, and flair tumor) on a large-scale MRI database. Thus, a CNN architecture is modified based on domain knowledge and connected with an evolutionary optimization algorithm to select hyperparameters. In parallel, a Stack Encoder-Decoder network is designed with ten convolutional layers. The features of both models are extracted and optimized using an improved version of Grey Wolf with updated criteria of the Jaya algorithm. The improved version speeds up the learning process and improves the accuracy. Finally, the selected features are fused using a novel parallel pooling approach that is classified using machine learning and neural networks. Two datasets, BraTS2020 and BraTS2021, have been employed for the experimental tasks and obtained an improved average accuracy of 98% and a maximum single-classifier accuracy of 99%. Comparison is also conducted with several classifiers, techniques, and neural nets; the proposed method achieved improved performance.

The purpose of this systematic review was to summarize the results of original research studies evaluating the characteristics and performance of deep learning models for detection of knee ligament and meniscus tears on MRI.

We searched PubMed for studies published as of February 2, 2022 for original studies evaluating development and evaluation of deep learning models for MRI diagnosis of knee ligament or meniscus tears. We summarized study details according to multiple criteria including baseline article details, model creation, deep learning details, and model evaluation.

19 studies were included with radiology departments leading the publications in deep learning development and implementation for detecting knee injuries via MRI. Among the studies, there was a lack of standard reporting and inconsistently described development details. However, all included studies reported consistently high model performance that significantly supplemented human reader performance.

From our review, we found radiology departments have been leading deep learning development for injury detection on knee MRIs. Although studies inconsistently described DL model development details, all reported high model performance, indicating great promise for DL in knee MRI analysis.

We previously validated Fibresolve, a machine learning classifier system that non-invasively predicts idiopathic pulmonary fibrosis (IPF) diagnosis. The system incorporates an automated deep learning algorithm that analyzes chest computed tomography (CT) imaging to assess for features associated with idiopathic pulmonary fibrosis. Here, we assess performance in assessment of patterns beyond those that are characteristic features of usual interstitial pneumonia (UIP) pattern. The machine learning classifier was previously developed and validated using standard training, validation, and test sets, with clinical plus pathologically determined ground truth. The multi-site 295-patient validation dataset was used for focused subgroup analysis in this investigation to evaluate the classifier's performance range in cases with and without radiologic UIP and probable UIP designations. Radiologic assessment of specific features for UIP including the presence and distribution of reticulation, ground glass, bronchiectasis, and honeycombing was used for assignment of radiologic pattern. Output from the classifier was assessed within various UIP subgroups. The machine learning classifier was able to classify cases not meeting the criteria for UIP or probable UIP as IPF with estimated sensitivity of 56-65% and estimated specificity of 92-94%. Example cases demonstrated non-basilar-predominant as well as ground glass patterns that were indeterminate for UIP by subjective imaging criteria but for which the classifier system was able to correctly identify the case as IPF as confirmed by multidisciplinary discussion generally inclusive of histopathology. The machine learning classifier Fibresolve may be helpful in the diagnosis of IPF in cases without radiological UIP and probable UIP patterns.

Background Deep learning (DL)-accelerated MRI can substantially reduce examination times. However, studies prospectively evaluating the diagnostic performance of DL-accelerated MRI reconstructions in acute suspected stroke are lacking. Purpose To investigate the interchangeability of DL-accelerated MRI with conventional MRI in patients with suspected acute ischemic stroke at 1.5 T. Materials and Methods In this prospective study, 211 participants with suspected acute stroke underwent clinically indicated MRI at 1.5 T between June 2022 and March 2023. For each participant, conventional MRI (including T1-weighted, T2-weighted, T2*-weighted, T2 fluid-attenuated inversion-recovery, and diffusion-weighted imaging; 14 minutes 18 seconds) and DL-accelerated MRI (same sequences; 3 minutes 4 seconds) were performed. The primary end point was the interchangeability between conventional and DL-accelerated MRI for acute ischemic infarction detection. Secondary end points were interchangeability regarding the affected vascular territory and clinically relevant secondary findings (eg, microbleeds, neoplasm). Three readers evaluated the overall occurrence of acute ischemic stroke, affected vascular territory, clinically relevant secondary findings, overall image quality, and diagnostic confidence. For acute ischemic lesions, size and signal intensities were assessed. The margin for interchangeability was chosen as 5%. For interrater agreement analysis and interrater reliability analysis, multirater Fleiss κ and the intraclass correlation coefficient, respectively, was determined. Results The study sample consisted of 211 participants (mean age, 65 years ± 16 [SD]); 123 male and 88 female). Acute ischemic stroke was confirmed in 79 participants. Interchangeability was demonstrated for all primary and secondary end points. No individual equivalence indexes (IEIs) exceeded the interchangeability margin of 5% (IEI, -0.002 [90% CI: -0.007, 0.004]). Almost perfect interrater agreement was observed (P > .91). DL-accelerated MRI provided higher overall image quality (P < .001) and diagnostic confidence (P < .001). The signal properties of acute ischemic infarctions were similar in both techniques and demonstrated good to excellent interrater reliability (intraclass correlation coefficient, ≥0.8). Conclusion Despite being four times faster, DL-accelerated brain MRI was interchangeable with conventional MRI for acute ischemic lesion detection. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Haller in this issue.

In recent years, machine learning (ML) and deep learning (DL) have been the leading approaches to solving various challenges, such as disease predictions, drug discovery, medical image analysis, etc., in intelligent healthcare applications. Further, given the current progress in the fields of ML and DL, there exists the promising potential for both to provide support in the realm of healthcare. This study offered an exhaustive survey on ML and DL for the healthcare system, concentrating on vital state of the art features, integration benefits, applications, prospects and future guidelines. To conduct the research, we found the most prominent journal and conference databases using distinct keywords to discover scholarly consequences. First, we furnished the most current along with cutting-edge progress in ML-DL-based analysis in smart healthcare in a compendious manner. Next, we integrated the advancement of various services for ML and DL, including ML-healthcare, DL-healthcare, and ML-DL-healthcare. We then offered ML and DL-based applications in the healthcare industry. Eventually, we emphasized the research disputes and recommendations for further studies based on our observations.

Coronary artery disease (CAD) has the highest mortality rate; therefore, its diagnosis is vital. Intravascular ultrasound (IVUS) is a high-resolution imaging solution that can image coronary arteries, but the diagnosis software via wall segmentation and quantification has been evolving. In this study, a deep learning (DL) paradigm was explored along with its bias.

Using a PRISMA model, 145 best UNet-based and non-UNet-based methods for wall segmentation were selected and analyzed for their characteristics and scientific and clinical validation. This study computed the coronary wall thickness by estimating the inner and outer borders of the coronary artery IVUS cross-sectional scans. Further, the review explored the bias in the DL system for the first time when it comes to wall segmentation in IVUS scans. Three bias methods, namely (i) ranking, (ii) radial, and (iii) regional area, were applied and compared using a Venn diagram. Finally, the study presented explainable AI (XAI) paradigms in the DL framework.

UNet provides a powerful paradigm for the segmentation of coronary walls in IVUS scans due to its ability to extract automated features at different scales in encoders, reconstruct the segmented image using decoders, and embed the variants in skip connections. Most of the research was hampered by a lack of motivation for XAI and pruned AI (PAI) models. None of the UNet models met the criteria for bias-free design. For clinical assessment and settings, it is necessary to move from a paper-to-practice approach.

Large numbers of radiographic images are available in musculoskeletal radiology practices which could be used for training of deep learning models for diagnosis of knee abnormalities. However, those images do not typically contain readily available labels due to limitations of human annotations. The purpose of our study was to develop an automated labeling approach that improves the image classification model to distinguish normal knee images from those with abnormalities or prior arthroplasty. The automated labeler was trained on a small set of labeled data to automatically label a much larger set of unlabeled data, further improving the image classification performance for knee radiographic diagnosis. We used BioBERT and EfficientNet as the feature extraction backbone of the labeler and imaging model, respectively. We developed our approach using 7382 patients and validated it on a separate set of 637 patients. The final image classification model, trained using both manually labeled and pseudo-labeled data, had the higher weighted average AUC (WA-AUC 0.903) value and higher AUC values among all classes (normal AUC 0.894; abnormal AUC 0.896, arthroplasty AUC 0.990) compared to the baseline model (WA-AUC = 0.857; normal AUC 0.842; abnormal AUC 0.848, arthroplasty AUC 0.987), trained using only manually labeled data. Statistical tests show that the improvement is significant on normal (p value < 0.002), abnormal (p value < 0.001), and WA-AUC (p value = 0.001). Our findings demonstrated that the proposed automated labeling approach significantly improves the performance of image classification for radiographic knee diagnosis, allowing for facilitating patient care and curation of large knee datasets.

To create the 3D convolutional neural network (CNN)-based system that can use whole-body [18F]FDG PET for recurrence/post-therapy surveillance in ovarian cancer (OC).

In this study, 1224 image sets from OC patients who underwent whole-body [18F]FDG PET/CT at Kowsar Hospital between April 2019 and May 2022 were investigated. For recurrence/post-therapy surveillance, diagnostic classification as cancerous, and non-cancerous and staging as stage III, and stage IV were determined by pathological diagnosis and specialists' interpretation. New deep neural network algorithms, the OCDAc-Net, and the OCDAs-Net were developed for diagnostic classification and staging of OC patients using [18F]FDG PET/CT images. Examinations were divided into independent training (75%), validation (10%), and testing (15%) subsets.

This study included 37 women (mean age 56.3 years; age range 36-83 years). Data augmentation techniques were applied to the images in two phases. There were 1224 image sets for diagnostic classification and staging. For the test set, 170 image sets were considered for diagnostic classification and staging. The OCDAc-Net areas under the receiver operating characteristic curve (AUCs) and overall accuracy for diagnostic classification were 0.990 and 0.92, respectively. The OCDAs-Net achieved areas under the receiver operating characteristic curve (AUCs) of 0.995 and overall accuracy of 0.94 for staging.

The proposed 3D CNN-based models provide potential tools for recurrence/post-therapy surveillance in OC. The OCDAc-Net and the OCDAs-Net model provide a new prognostic analysis method that can utilize PET images without pathological findings for diagnostic classification and staging.

Stone formation in the kidneys is a common disease, and the high rate of recurrence and morbidity of the disease worries all patients with kidney stones. There are many imaging options for diagnosing and managing kidney stone disease, and CT imaging is the preferred method.

Radiologists need to manually analyse large numbers of CT slices to diagnose kidney stones, and this process is laborious and time-consuming. This study used deep automated learning (DL) algorithms to analyse kidney stones. The primary purpose of this study is to classify kidney stones accurately from CT scans using deep learning algorithms.

The Inception-V3 model was selected as a reference in this study. Pre-trained with other CNN architectures were applied to a recorded dataset of abdominal CT scans of patients with kidney stones labelled by a radiologist. The minibatch size has been modified to 7, and the initial learning rate was 0.0085.

The performance of the eight models has been analysed with 8209 CT images recorded at the hospital for the first time. The training and test phases were processed with limited authentic recorded CT images. The outcome result of the test shows that the Inception-V3 model has a test accuracy of 98.52 % using CT images in detecting kidney stones.

The observation is that the Inception-V3 model is successful in detecting kidney stones of small size. The performance of the Inception-V3 Model is at a high level and can be used for clinical applications. The research helps the radiologist identify kidney stones with less computational cost and disregards the need for many experts for such applications.

Deep learning (DL) reconstruction techniques to improve MR image quality are becoming commercially available with the hope that they will be applicable to multiple imaging application sites and acquisition protocols. However, before clinical implementation, these methods must be validated for specific use cases. In this work, the quality of standard-of-care (SOC) T2w and a high-spatial-resolution (HR) imaging of the breast were assessed both with and without prototype DL reconstruction. Studies were performed using data collected from phantoms, 20 retrospectively collected SOC patient exams, and 56 prospectively acquired SOC and HR patient exams. Image quality was quantitatively assessed via signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and edge sharpness. Qualitatively, all in vivo images were scored by either two or four radiologist readers using 5-point Likert scales in the following categories: artifacts, perceived sharpness, perceived SNR, and overall quality. Differences in reader scores were tested for significance. Reader preference and perception of signal intensity changes were also assessed. Application of the DL resulted in higher average SNR (1.2-2.8 times), CNR (1.0-1.8 times), and image sharpness (1.2-1.7 times). Qualitatively, the SOC acquisition with DL resulted in significantly improved image quality scores in all categories compared to non-DL images. HR acquisition with DL significantly increased SNR, sharpness, and overall quality compared to both the non-DL SOC and the non-DL HR images. The acquisition time for the HR data only required a 20% increase compared to the SOC acquisition and readers typically preferred DL images over non-DL counterparts. Overall, the DL reconstruction demonstrated improved T2w image quality in clinical breast MRI.

New technologies are increasingly widespread in biomedicine. Using the consensus definition of new technologies established by the New Technologies Ad-Hoc Committee of the Spanish Society of Neurology (SEN), we evaluated the impact of these technologies on Spanish neurology, based on communications presented at Annual Meetings of the SEN.

We defined the concept of new technology in neurology as a novel technology or novel application of an existing technology, characterised by a certain degree of coherence persisting over time, with the potential to have an impact on the present and/or future of neurology. We conducted a descriptive study of scientific communications presented at the SEN's annual meetings from 2012 to 2018, analysing the type of technology, the field of neurology, and the geographical provenance of the studies.

We identified 299 communications related with new technologies from a total of 8139 (3.7%), including 120 posters and 179 oral communications, ranging from 1.6% of all communications in 2012 to 6.8% in 2018. The technologies most commonly addressed were advanced neuroimaging (24.7%), biosensors (17.1%), electrophysiology and neurostimulation (14.7%), and telemedicine (13.7%). The neurological fields where new technologies were most widely employed were movement disorders (18.4%), cerebrovascular diseases (15.7%), and dementia (13.4%). Madrid was the region presenting the highest number of communications related to new technologies (32.8%), followed by Catalonia (26.8%) and Andalusia (9.0%).

The number of communications addressing new technologies follows an upward trend. The number of technologies used in neurology has increased in parallel with their availability. We found scientific communications in all neurological subspecialties, with a heterogeneous geographical distribution.

The rapid advances in deep learning-based computational pathology and radiology have demonstrated the promise of using whole slide images (WSIs) and radiology images for survival prediction in cancer patients. However, most image-based survival prediction methods are limited to using either histology or radiology alone, leaving integrated approaches across histology and radiology relatively underdeveloped. There are two main challenges in integrating WSIs and radiology images: (1) the gigapixel nature of WSIs and (2) the vast difference in spatial scales between WSIs and radiology images. To address these challenges, in this work, we propose an interpretable, weakly-supervised, multimodal learning framework, called Hierarchical Multimodal Co-Attention Transformer (HMCAT), to integrate WSIs and radiology images for survival prediction. Our approach first uses hierarchical feature extractors to capture various information including cellular features, cellular organization, and tissue phenotypes in WSIs. Then the hierarchical radiology-guided co- attention (HRCA) in HMCAT characterizes the multimodal interactions between hierarchical histology-based visual concepts and radiology features and learns hierarchical co- attention mappings for two modalities. Finally, HMCAT combines their complementary information into a multimodal risk score and discovers prognostic features from two modalities by multimodal interpretability. We apply our approach to two cancer datasets (365 WSIs with matched magnetic resonance [MR] images and 213 WSIs with matched computed tomography [CT] images). Our results demonstrate that the proposed HMCAT consistently achieves superior performance over the unimodal approaches trained on either histology or radiology data alone, as well as other state-of-the-art methods.

Parkinson's disease (PD) is characterized by the loss of neuronal cells, which leads to synaptic dysfunction and cognitive defects. Despite the advancements in treatment strategies, the management of PD is still a challenging event. Early prediction and diagnosis of PD are of utmost importance for effective management of PD. In addition, the classification of patients with PD as compared to normal healthy individuals also imposes drawbacks in the early diagnosis of PD. To address these challenges, artificial intelligence (AI) and machine learning (ML) models have been implicated in the diagnosis, prediction, and treatment of PD. Recent times have also demonstrated the implication of AI and ML models in the classification of PD based on neuroimaging methods, speech recording, gait abnormalities, and others. Herein, we have briefly discussed the role of AI and ML in the diagnosis, treatment, and identification of novel biomarkers in the progression of PD. We have also highlighted the role of AI and ML in PD management through altered lipidomics and gut-brain axis. We briefly explain the role of early PD detection through AI and ML algorithms based on speech recordings, handwriting patterns, gait abnormalities, and neuroimaging techniques. Further, the review discuss the potential role of the metaverse, the Internet of Things, and electronic health records in the effective management of PD to improve the quality of life. Lastly, we also focused on the implementation of AI and ML-algorithms in neurosurgical process and drug discovery.

Depression is increasingly prevalent, leading to higher suicide risk. Depression detection and sentimental analysis of text inputs in cross-domain frameworks are challenging. Solo deep learning (SDL) and ensemble deep learning (EDL) models are not robust enough. Recently, attention mechanisms have been introduced in SDL. We hypothesize that attention-enabled EDL (aeEDL) architectures are superior compared to attention-not-enabled SDL (aneSDL) or aeSDL models. We designed EDL-based architectures with attention blocks to build eleven kinds of SDL model and five kinds of EDL model on four domain-specific datasets. We scientifically validated our models by comparing "seen" and "unseen" paradigms (SUP). We benchmarked our results against the SemEval (2016) sentimental dataset and established reliability tests. The mean increase in accuracy for EDL over their corresponding SDL components was 4.49%. Regarding the effect of attention block, the increase in the mean accuracy (AUC) of aeSDL over aneSDL was 2.58% (1.73%), and the increase in the mean accuracy (AUC) of aeEDL over aneEDL was 2.76% (2.80%). When comparing EDL vs. SDL for non-attention and attention, the mean aneEDL was greater than aneSDL by 4.82% (3.71%), and the mean aeEDL was greater than aeSDL by 5.06% (4.81%). For the benchmarking dataset (SemEval), the best-performing aeEDL model (ALBERT+BERT-BiLSTM) was superior to the best aeSDL (BERT-BiLSTM) model by 3.86%. Our scientific validation and robust design showed a difference of only 2.7% in SUP, thereby meeting the regulatory constraints. We validated all our hypotheses and further demonstrated that aeEDL is a very effective and generalized method for detecting symptoms of depression in cross-domain settings.

Currently, deep learning aided medical imaging is becoming the hot spot of AI frontier application and the future development trend of precision neuroscience. This review aimed to render comprehensive and informative insights into the recent progress of deep learning and its applications in medical imaging for brain monitoring and regulation. The article starts by providing an overview of the current methods for brain imaging, highlighting their limitations and introducing the potential benefits of using deep learning techniques to overcome these limitations. Then, we further delve into the details of deep learning, explaining the basic concepts and providing examples of how it can be used in medical imaging. One of the key strengths is its thorough discussion of the different types of deep learning models that can be used in medical imaging including convolutional neural networks (CNNs), recurrent neural networks (RNNs), and generative adversarial network (GAN) assisted magnetic resonance imaging (MRI), positron emission tomography (PET)/computed tomography (CT), electroencephalography (EEG)/magnetoencephalography (MEG), optical imaging, and other imaging modalities. Overall, our review on deep learning aided medical imaging for brain monitoring and regulation provides a referrable glance for the intersection of deep learning aided neuroimaging and brain regulation.